• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3'-5'核酸外切酶对“活化”环磷酰胺的酶促毒化作用。

Enzymatic toxicogenation of "activated" cyclophosphamide by 3'-5' exonucleases.

作者信息

Bielicki L, Voelcker G, Hohorst H J

出版信息

J Cancer Res Clin Oncol. 1983;105(1):27-9. doi: 10.1007/BF00391828.

DOI:10.1007/BF00391828
PMID:6300134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12252723/
Abstract

3'-5' Exonucleases from various sources were found to toxicogenate 4-hydroxycyclophosphamide ("activated" cyclophosphamide) by splitting the oxazaphosphorinane ring and releasing an alkylating moiety and acrolein. Neither cyclophosphamide (CP) nor the deactivated metabolites of CP, 4-keto-CP and carboxyphosphamide nor 4-(S-ethanol)-sulfido-CP were attacked by 3'-5' exonucleases. DNA polymerases with proofreading activity, such as DNA polymerase I from E. coli or DNA polymerase delta from rabbit bone marrow, exhibited a tenfold higher specific activity with "activated" CP than "plain" 3'-5' phosphodiesterases such as snake venom phosphodiesterase or 3',5'cyclic AMP phosphodiesterase from bovine heart tissue. High levels of toxicogenating activity were estimated in peripheric human lymphocytes and tissues of lymphatic origin, suggesting that enzymatic toxicogenation plays a key role with respect to the cytotoxic specificity of "activated" CP.

摘要

研究发现,来自各种来源的3'-5'核酸外切酶可通过裂解氧氮磷杂环戊烷环并释放烷基化部分和丙烯醛,使4-羟基环磷酰胺(“活化”环磷酰胺)产生毒化作用。环磷酰胺(CP)及其失活代谢产物4-酮基-CP、羧基磷酰胺以及4-(S-乙醇)-硫代-CP均不会受到3'-5'核酸外切酶的作用。具有校对活性的DNA聚合酶,如大肠杆菌的DNA聚合酶I或兔骨髓的DNA聚合酶δ,对“活化”CP的比活性比对“普通”3'-5'磷酸二酯酶(如蛇毒磷酸二酯酶或牛心脏组织的3',5'-环磷酸腺苷磷酸二酯酶)高十倍。在人外周淋巴细胞和淋巴源性组织中检测到高水平的毒化活性,这表明酶促毒化作用在“活化”CP的细胞毒性特异性方面起着关键作用。

相似文献

1
Enzymatic toxicogenation of "activated" cyclophosphamide by 3'-5' exonucleases.3'-5'核酸外切酶对“活化”环磷酰胺的酶促毒化作用。
J Cancer Res Clin Oncol. 1983;105(1):27-9. doi: 10.1007/BF00391828.
2
Activated cyclophosphamide: an enzyme-mechanism-based suicide inactivator of DNA polymerase/3'-5' exonuclease.活化环磷酰胺:一种基于酶机制的DNA聚合酶/3'-5'核酸外切酶自杀性灭活剂。
J Cancer Res Clin Oncol. 1984;107(3):195-8. doi: 10.1007/BF01032606.
3
The enzymatic basis of cyclophosphamide specificity.环磷酰胺特异性的酶学基础。
Adv Enzyme Regul. 1986;25:99-122. doi: 10.1016/0065-2571(86)90010-5.
4
Does acrolein contribute to the cytotoxicity of cyclophosphamide?丙烯醛是否对环磷酰胺的细胞毒性有影响?
J Cancer Res Clin Oncol. 1980;98(2):119-26. doi: 10.1007/BF00405956.
5
Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.噻唑烷基和全氢噻嗪基磷酰胺酯:毒性及初步抗肿瘤评估
J Cancer Res Clin Oncol. 1997;123(11-12):623-31. doi: 10.1007/s004320050116.
6
Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.通过改良荧光测定法对活化异环磷酰胺和环磷酰胺人体药代动力学的比较研究。
J Cancer Res Clin Oncol. 1981;100(1):95-104. doi: 10.1007/BF00405906.
7
[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].人体内活化环磷酰胺及其失活产物的血药浓度和尿排泄情况(作者译)
J Cancer Res Clin Oncol. 1980 Jan;96(1):79-92. doi: 10.1007/BF00412899.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.美司钠和半胱氨酸对活化环磷酰胺全身毒性及治疗效果的影响。
J Cancer Res Clin Oncol. 1987;113(2):160-5. doi: 10.1007/BF00391439.

引用本文的文献

1
Enhancement of antitumor activity of the oxazaphosphorine cytostatic SUM-IAP by N-methylformamide.N-甲基甲酰胺增强恶唑磷氮芥类细胞抑制剂SUM-IAP的抗肿瘤活性。
J Cancer Res Clin Oncol. 2016 Jun;142(6):1183-9. doi: 10.1007/s00432-016-2132-5. Epub 2016 Mar 3.
2
Ifosfamide clinical pharmacokinetics.异环磷酰胺的临床药代动力学。
Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003.
3
Activated cyclophosphamide: an enzyme-mechanism-based suicide inactivator of DNA polymerase/3'-5' exonuclease.活化环磷酰胺:一种基于酶机制的DNA聚合酶/3'-5'核酸外切酶自杀性灭活剂。
J Cancer Res Clin Oncol. 1984;107(3):195-8. doi: 10.1007/BF01032606.
4
Low toxicity cancer chemotherapy by suicide inactivation of DNA polymerase alpha holoenzyme: first results with new thiazolidinyl- and perhydrothiazinyl-ethyl-N-mustard-phosphamide esters.通过DNA聚合酶α全酶的自杀失活实现低毒性癌症化疗:新型噻唑烷基和全氢噻嗪基乙基氮芥磷酰胺酯的初步结果
J Cancer Res Clin Oncol. 1988;114(3):309-11. doi: 10.1007/BF00405840.
5
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites.骨髓移植中重复高剂量环磷酰胺给药:暴露于活性代谢产物。
Cancer Chemother Pharmacol. 1987;20(3):248-52. doi: 10.1007/BF00570495.
6
Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.环磷酰胺和磷酰胺芥在大鼠体内的脑和血浆药代动力学及抗癌活性
Cancer Chemother Pharmacol. 1990;27(1):1-7. doi: 10.1007/BF00689268.

本文引用的文献

1
Purification of deoxyribonucleic acid polymerase delta from calf thymus: partial characterization of physical properties.从小牛胸腺中纯化脱氧核糖核酸聚合酶δ:物理性质的部分表征
Biochemistry. 1980 May 13;19(10):2096-101. doi: 10.1021/bi00551a015.
2
Structural and functional properties of calf thymus DNA polymerase delta.小牛胸腺DNA聚合酶δ的结构与功能特性
Prog Nucleic Acid Res Mol Biol. 1981;26:83-96. doi: 10.1016/s0079-6603(08)60396-7.
3
Fluorometric determination of acrolein and related compounds with m-aminophenol.用间氨基酚荧光法测定丙烯醛及相关化合物
Anal Chem. 1968 Sep;40(11):1704-8. doi: 10.1021/ac60267a019.
4
Isolation and identification of 4-ketocyclophosphamide, a possible active form of the antitumor agent cyclophosphamide.抗肿瘤药物环磷酰胺的一种可能活性形式——4-酮环磷酰胺的分离与鉴定。
J Am Chem Soc. 1970 May 20;92(10):3207-8. doi: 10.1021/ja00713a060.
5
Urinary metabolites of the antitumor agent cyclophosphamide.抗肿瘤药物环磷酰胺的尿液代谢产物。
Mol Pharmacol. 1971 Sep;7(5):519-29.
6
Enzymatic synthesis of deoxyribonucleic acid. 36. A proofreading function for the 3' leads to 5' exonuclease activity in deoxyribonucleic acid polymerases.脱氧核糖核酸的酶促合成。36. 脱氧核糖核酸聚合酶中3'至5'核酸外切酶活性的校对功能。
J Biol Chem. 1972 Jan 10;247(1):241-8.
7
Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.4-氢过氧环磷酰胺(NSC-181815)的研究:一种简单的制备方法及其在合成新型“活性”含硫环磷酰胺(NSC-26271)衍生物中的应用。
Cancer Treat Rep. 1976 Apr;60(4):429-35.
8
Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.巯基化合物对环磷酰胺(NSC - 26271)代谢物的失活作用。
Cancer Treat Rep. 1976 Apr;60(4):355-9.
9
The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.环磷酰胺(NSC - 26271)的肿瘤生长抑制特异性问题:关于控制烷基化和细胞毒性活性反应的研究
Cancer Treat Rep. 1976 Apr;60(4):309-15.
10
A new mammalian DNA polymerase with 3' to 5' exonuclease activity: DNA polymerase delta.一种具有3'至5'核酸外切酶活性的新型哺乳动物DNA聚合酶:DNA聚合酶δ
Biochemistry. 1976 Jun 29;15(13):2817-23. doi: 10.1021/bi00658a018.